The Washington Post reported Thursday that Trump has long taken a drug for hair loss called finasteride. It's no longer listed on his medical records. Another majorThe Washington Post reported Thursday that Trump has long taken a drug for hair loss called finasteride. It's no longer listed on his medical records. Another major

New Trump health info reveals 'something going on with his prostate': GOP White House doc

2026/06/04 20:26
Okuma süresi: 4 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

The Washington Post reported Thursday that Trump has long taken a drug for hair loss called finasteride. It's no longer listed on his medical records. Another major finding is that his prostate-specific antigen (PSA) test exploded tenfold over the last year.

It's prompting Dr. Jonathan Reiner, professor of medicine and surgery and CNN medical analyst, to raise questions.

The hair loss drug Trump took, commonly known as Propecia, is used by millions to protect against hair loss. Trump's hair has long been a major part of his identity. His combover covers a growing balding spot on the back of his head.

However, the drug is "also is used as a treatment to prevent prostate cancer. People who take finasteride report lower levels of prostate-specific antigen (PSA) in their bloodstream, a marker of potential prostate cancer," the Post said.

Since returning to office, however, the medication has disappeared from his charts. He took it in his first administration. Now his PSA has significantly increased. It doesn't mean he has prostate cancer, but it's sending up red flags to other physicians who believe Americans deserve to know the details.

“The current report reflects all medications deemed clinically relevant to disclose at this time,” the White House told the Post in a statement. “No additional undisclosed conditions or procedures materially affecting his health status were omitted from this report.”

They claimed that Trump’s latest medical report contained information relevant to his ability to serve in office.

Trump allies have mocked those questioning Trump's health and advanced age. Robert Klitzman, a psychiatrist who leads Columbia University’s master’s program in bioethics, told the Post that the White House isn't known for its honesty about such matters.

For example, Trump and the White House also concealed the seriousness of Trump's coronavirus infection in 2020 when it became so bad that he needed supplemental oxygen and had to be rushed to Walter Reed. There were a lot of "mixed messages" in the reporting on that issue at the time, The Guardian pointed out.

“It raises significant questions of what else is possibly not being revealed,” Klitzman said.

Hair loss, while devastating for some, isn't debilitating. But Klitzman explained that one of the side effects of the drug finasteride is an increased risk of depression. The president's emotional state could impact his performance. Trump is already known for his volatility. Now it appears he might also also face severe insomnia, as Secretary of State Marco Rubio confirmed in a hearing Wednesday. Insomnia can also have a significant impact on a person's emotional state.

The doctor called it “crucial” for the White House to be transparent about all of Trump's medications and overall health.

Another concern is a major change in Trump's prostate-specific antigen (PSA) test.

In 2025, it was revealed that former President Joe Biden has stage 4 metastatic prostate cancer that has already spread to his bones. Prostate cancer isn't curable, but it can be slowed so significantly that the person with it can die from other factors. Biden's wasn't caught early enough to begin slowing the progression.

The diagnosis became a huge story, as many implied that the White House was "hiding" his diagnosis and that he was far more infirm than leading on. The American Urological Association advises against routine prostate cancer screening (PSA tests) for men over 70.

Dr. Reiner wants to know if Trump stopped taking the finasteride drug because his PSA went up from 0.1 last year to 1.0 now.

"Did he stop taking the drug, or is he still taking it and now there’s something going on with his prostate? That’s why it’s important," he said.

The Post noted past presidents who have also concealed details about their health, like when Woodrow Wilson had a stroke or John F. Kennedy was using powerful painkillers.

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Piyasa Fırsatı
OFFICIAL TRUMP Logosu
OFFICIAL TRUMP Fiyatı(TRUMP)
$1.863
$1.863$1.863
-6.05%
USD
OFFICIAL TRUMP (TRUMP) Canlı Fiyat Grafiği

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

SanDisk (SNDK) Stock Soars 7% as Analysts Boost Price Targets to Record Levels

SanDisk (SNDK) Stock Soars 7% as Analysts Boost Price Targets to Record Levels

SanDisk (SNDK) stock climbs 6.7% to record high after Morgan Stanley raises target to $1,750 and Barclays upgrades. NAND demand outlook boosts rally. The post SanDisk
Paylaş
Blockonomi2026/06/04 21:12
SanDisk (SNDK) Stock Jumps 7% to New All-Time High — And Wall Street Wants More

SanDisk (SNDK) Stock Jumps 7% to New All-Time High — And Wall Street Wants More

TLDR SanDisk stock rose over 6.7%, hitting a new all-time high of $1,861 on Wednesday Morgan Stanley reiterated its Overweight rating and raised its price target
Paylaş
Coincentral2026/06/04 21:03
Fed expected to cut rates by 25 bps, Bitcoin and Ethereum steady

Fed expected to cut rates by 25 bps, Bitcoin and Ethereum steady

The post Fed expected to cut rates by 25 bps, Bitcoin and Ethereum steady appeared on BitcoinEthereumNews.com. News Jenny Johnson predicts a 25 basis point Fed rate cut, citing strong wage growth and retail sales despite sticky 3% inflation. Scott Melker expects a cautious 25 basis point cut, with Powell’s speech focusing on data driven decisions. Bitcoin and Ethereum are steady, but a hint of more cuts by year-end could spark a market rally. The Federal Reserve announced its interest rate decision. On CNBC, Jenny Johnson, the CEO of Franklin Templeton, shared her take, betting on a small 25 basis point rate cut rather than a bigger 50 basis point one. She mentioned recent job numbers that show a softening labor market, but she thinks those figures are old news. Instead, she pointed to strong wage growth and growing retail sales, which show people are still spending despite inflation hanging around 3%. What’s Driving the Fed’s Next Move Johnson feels a 25 basis point cut is the smart play for Fed Chair Jerome Powell. She noted there’s room to cut rates more in October or December if the economy calls for it. The economy looks solid, she said, but Powell’s comments at Jackson Hole about a weaker job market mean no rate cut isn’t an option. Market expert Scott Melker agrees, expecting a cautious 25 basis point cut, with Powell likely to stress that future moves depend on data without promising more cuts soon. Meanwhile, former President Donald Trump is pushing for a larger cut. Bitcoin, Ethereum, and other cryptocurrencies are holding steady as investors wait for Powell’s speech. Analyst Kevin Capital says the market already expects the cut, but if Powell hints at more cuts by year-end, we could see a rally. Everyone’s watching to see what Powell says next. Source: https://thenewscrypto.com/fed-expected-to-cut-rates-by-25-bps-bitcoin-and-ethereum-steady/
Paylaş
BitcoinEthereumNews2025/09/18 12:46

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage